Hi-Tech Pharmacal Co. (NASDAQ:HITK) Investor Alert: Investigation over Takeover for $43.50 Per Share
An investigation on behalf of investors, who currently hold shares of Hi-Tech Pharmacal Co. (NASDAQ:HITK) shares, was announced concerning whether the takeover of Hi-Tech Pharmacal Co. by Akorn, Inc.for $43.50 per NASDAQ:HITK share is unfair to Hi-Tech Pharmacal stockholders.
View full press release